Go to deals
TMT

RT-RK d.o.o. has completed a fairness opinion process

RT-RK d.o.o. has obtained a fairness opinion.

Founded in 1991, RT-RK is an R&D company and national research institute that delivers development services and own products in the area of real time embedded systems, with strong focus on consumer electronics and automotive. Headquartered in Novi Sad, with offices in Belgrade (Serbia), Banja Luka (Bosnia and Herzegovina) and Osijek (Croatia) and with over 600 engineers, RT-RK is one of the biggest development houses in Southeast Europe.

Oaklins' team in Austria acted as financial advisor in the valuation process of RT-RK d.o.o. providing a fairness opinion to determine whether the agreed purchase price for the shares of the company was compliant with the fair value.

Talk to the deal team

Thomas Jungreithmeir

Managing Partner
Vienna, Austria
Oaklins Austria

Related deals

BodhiCedric has acquired Network Media from Jellysmack
TMT

BodhiCedric has acquired Network Media from Jellysmack

The media holding company BodhiCedric has acquired Network Media, an innovator in the creator economy, from Jellysmack, the global creator company.

Learn more
CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
TMT

CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions

Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.

Learn more
Bayer AG has entered into a takeover agreement with Cara Care
Healthcare | TMT

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Learn more